| [1] |
叶腾，吕吟秋，陈波，等. 温州市成人原发性肾小球疾病病理类型构成比20年演变[J]. 温州医科大学学报，2015, 45(8): 574-578.
|
| [2] |
Nonaka K, Ubara Y, Suwabe T, et al. Intractable membranous lupus nephritis showing selective improvement of subepithelial deposits with tacrolimus therapy: a case report [J]. Clin Nephrol, 2013, 80(2): 140-145.
|
| [3] |
Faul C, Donnelly M, Merscher－Gomez S, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A [J]. Nat Med, 2008, 14(9): 931-938.
|
| [4] |
McCauley J, Tzakis AG, Fung JJ, et al. FK506 in steroid－resistant focal sclerosing glomerulonephritis of childhood [J]. Lancet, 1990, 335(8690): 674.
|
| [5] |
Chen W, Liu Q, Liao Y, et al. Outcomes of tacrolimus therapy in adults with refractory membranous nephrotic syndrome: a prospective, multicenter clinical trial [J]. Am J Med Sci, 2013, 345(2): 81-87.
|
| [6] |
He L, Peng Y, Liu H, et al. Treatment of idiopathic membranous nephropathy with combination of low－dose tacrolimus and corticosteroids [J]. J Nephrol, 2013, 26(3): 564-571.
|
| [7] |
Praga M, Barrio V, Juárez GF, et al. Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial [J]. Kidney Int, 2007, 71(9): 924-930.
|
| [8] |
Fan L, Liu Q, Liao Y, et al. Tacrolimus is an alternative therapy option for the treatment of adult steroid－resistant nephrotic syndrome: a prospective, multicenter clinical trial [J]. Int Urol Nephrol, 2013, 45(2): 459-468.
|
| [9] |
Cui W, Lu X, Min X, et al. Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy [J]. Braz J Med Biol Res, 2017, 50(4): e5976.
|
| [10] |
周广宇，郭莹，张力，等. 他克莫司联合激素治疗特发性膜性肾病疗效及其抗PLA2R抗体对治疗的反应[J]．吉林大学学报(医学版), 2016, 42(5): 937-941.
|
| [11] |
Zhu LB, Liu LL, Yao L, et al. Efficacy and safety of tacrolimus versus cyclophosphamide for primary membranous nephropathy: a meta－analysis [J]. Drugs, 2017, 77(2): 187-199.
|
| [12] |
Santosh T, Liu H, Liu B. Effect of tacrolimus in idiopathic membranous nephropathy: a meta－analysis [J]. Chin Med J (Engl), 2014, 127(14): 2693-2699.
|
| [13] |
Xu D, Gao X, Bian R, et al. Tacrolimus improves proteinuria remission in adults with cyclosporine A－resistant or －dependent minimal change disease [J]. Nephrology (Carlton), 2017, 22(3): 251-256.
|
| [14] |
Wang W, Xia Y, Mao J, et al. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome [J]. Pediatr Nephrol, 2012, 27(11): 2073-2079.
|
| [15] |
Sinha A, Gupta A, Kalaivani M, et al. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid－resistant nephrotic syndrome [J]. Kidney Int, 2017, 92(1): 248-257.
|
| [16] |
Hannah J, Casian A, D′Cruz D. Tacrolimus use in lupus nephritis: a systematic review and meta－analysis [J]. Autoimmun Rev, 2016, 15(1): 93-101.
|
| [17] |
Li X, Xu N, Li H, et al. Tacrolimus as rescue therapy for adult－onset refractory minimal change nephrotic syndrome with reversible acute renal failure [J]. Nephrol Dial Transplant, 2013, 28(9): 2306-2312.
|
| [18] |
Roberti I, Vyas S. Long－term outcome of children with steroid－resistant nephrotic syndrome treated with tacrolimus [J]. Pediatr Nephrol, 2010, 25(6): 1117-1124.
|
| [19] |
Yuan H, Liu N, Sun GD, et al. Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome [J]. Pharmacology, 2013, 91(5－6): 259-266.
|
| [20] |
窦涪琳. 长疗程他克莫司治疗特发性膜性肾病的临床疗效观察及长期随访[D]. 吉林大学，2016.
|
| [21] |
Yap DY, Ma MK, Mok MM, et al. Long－term data on tacrolimus treatment in lupus nephritis [J]. Rheumatology (Oxford), 2014, 53(12): 2232-2237.
|
| [22] |
Caro J, Gutiérrez－Solís E, Rojas－Rivera J, et al. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus [J]. Nephrol Dial Transplant, 2015, 30(3): 467-474.
|
| [23] |
Li X, Liu Z, Wang L, et al. Tacrolimus monotherapy after intravenous methylprednisolone in adults with minimal change nephrotic syndrome [J]. J Am Soc Nephrol, 2017, 28(4): 1286-1295.
|
| [24] |
Liang Q, Li H, Xie X, et al. The efficacy and safety of tacrolimus monotherapy in adult－onset nephrotic syndrome caused by idiopathic membranous nephropathy [J]. Ren Fail, 2017, 39(1): 512-518.
|
| [25] |
宋艳，成璐，贾淼鑫，等. 肾病综合征患者他克莫司血药浓度监测的回顾性分析与评价[J]. 中国医院药学杂志，2017, 37(7): 654-658.
|
| [26] |
Ren S, Wang Y, Xian L, et al. Comparative effective and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta－analysis [J]. PLoS One, 2017, 12(9): e0184398.
|
| [27] |
Zhang X, Ji L, Yang L, et al. The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta－analysis [J]. Int Urol Nephrol, 2016, 48(5): 731-743.
|
| [28] |
Qiu TT, Zhang C, Zhao HW, et al. Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy: A systematic review and meta－analysis of 21 clinical trials [J]. Autoimmun Rev, 2017, 16(2): 136-145.
|
| [29] |
Chen M, Li H, Li XY, et al. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial [J]. Am J Med Sci, 2010, 339(3): 233-238.
|
| [30] |
Butani L, Ramsamooj R. Experience with tacrolimus in children with steroid－resistant nephrotic syndrome [J]. Pediatr Nephrol, 2009, 24(8): 1517-1523.
|
| [31] |
Morgan C, Sis B, Pinsk M, et al. Renal interstitial fibrosis in children treated with FK506 for nephrotic syndrome [J]. Nephrol Dial Transplant, 2011, 26(9): 2860-2865.
|
| [32] |
李喆. 肾病综合征他克莫司治疗后急性肾损伤的临床特征及预后[D]. 南京大学，2015.
|